Modular manufacturing.
Built for optionality.
Spanance is a next-generation CDMO with an open design, supporting multiple modalities and program types while we co-create the right path with partners. From our site in Portugal, we accommodate select sterile and non-sterileprograms - including oral solid (e.g., tablets, capsules) and other dosage forms - as well as food-supplement opportunities, without compromising our trajectory focused on downstream operations and sterile injectable fill-finish.
ADVANCING SCIENCE,
ENHANCING LIFE
Location
(Mação, Santarém)
footprint
non-aseptic
rooms
HVAC
-injectables F&F
Location
(Mação, Santarém)
footprint
non-aseptic
rooms
HVAC
-injectables
F&F
ABOUT
A CDMO that keeps
options open
By specializing in downstream processes, Spanance provides a flexible model tailored to the fastest-growing segments of pharma. Our modular approach supports a broad range of therapeutic modalities and program sizes, with synergies across an integrated innovation ecosystem.
ABOUT
A CDMO that keeps
options open
By specializing in downstream processes, Spanance provides a flexible model tailored to the fastest-growing segments of pharma. Our modular approach supports a broad range of therapeutic modalities and program sizes, with synergies across an integrated innovation ecosystem.
Versatile facilities
Our 3,000 m² GMP-designed facility is engineered for versatility. Independent rooms with dedicated HVAC and a centralized BMS enable precise environmental control. The site can accommodate sterile and non-sterile medicines in multiple dosage forms, alongside medical devices, cosmetics, supplements, and related products.
Capabilities
What we can do today
We prioritize programs where our platform creates immediate value, with a phased pathway from low-barrier opportunities to higher-value pharmaceutical runs.
Commercial production of approved products
- GMP manufacturing for clients with approved dossiers
- Operational efficiency and batch consistency
- Continuous process optimization to maximize yield and reduce cost
End-to-end CMC support (Preclinical to Phase III)
- Formulation development and process scale-up
- Aseptic fill-finish; analytical and method validation
- Tech transfer and regulatory documentation
Medical devices, supplements, cosmetics
- Opportunistic manufacturing aligned with core capabilities
- Potential coordination with a co-located affiliate for tenders
- Integrated delivery where appropriate
Open for partnerships
We are actively exploring collaborations across pharma, biotech, and health-adjacent sectors. If you’re seeking a nimble manufacturing partner – or a site to anchor a program – let’s talk.
